Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
20 Cards in this Set
- Front
- Back
PCOS differential diagnosis (10 items)
|
Androgen secreting tumor, Exogenous androgens, cushing syndrome, nonclassical congenital adrenal hyperplasia, acromegaly, genetic defects in insulin action, primary hypothalamic amenorrhea, primary ovarian failure, thyroid disease, prolactin disorders
|
|
PCOS: diagnostic criteria
|
no universally accpeted definition, 3 different diagnostic criteria used (NIH 1990, Rotterdam 2003, androgen excess socitey 2006) all with variations of hyperandrogenism (on physical exam or lab value), oligo/amenorrhea, PCO on US
|
|
How common is obesity in PCOS?
|
80% will be obese
|
|
What is the suggested evaluation for patients on physical exam? (4 items)
|
physical: BP, BMI, waist circumference (>35 inches=abnormal), stigmata of hyperandrogenism (Acanthosis nigricans, alopecia, acne, hirsutism)
|
|
What is the suggested evaluation for patients on laborotory values?
|
total testosterone and SHBG OR bioavailable and free testerone, TSH, Prolactin, 17-hydroxyprogesterone (nonclassical congenital adrenal hyperplasia due to 21-hydroxylase deficiency: random normal <4ng /ml; fasting AM <2ng/ml), screening for other d/o if clinically indicated (Cushings, acromegaly) including glucose tolerance and lipids
|
|
How is a 2 hour glucose tolerance test conducted and what are the values with each glucose tested?
|
check fasting glucose (<110mg />125=type 2DM), 75g oral glucose load the check 2 hour glucose (<140mg />199=type2 DM)
|
|
What radiologic studies are considered in PCOS?
|
US 1 or both ovaries: ovarian volume>10cubic cm, >/= 12 follicles measuring 2-9mm. If a follicle in >10mm, re-evaluate later. Check uterus also.
|
|
Optional lab tests in PCOS (3)
|
gonadotropin levels, fasting insulin in younger women (not routinely recommended), 24h urinary free cortisol excretion or low dose dexamethasone supression (cushing's)
|
|
Define the metabolic syndrome (Grundy et al. Circulation, 2005). (5 elements)
|
BP>/= 135/85, increased waist circumference (>/=35inches), elevated fasting Glc, reduced HDL (</=50mg/dl), elevated TG level (>/=150 mg/dl)
|
|
Who should be screened for noncalssical congenital adrenal hyperplasia and how should screening be performed?
|
anovulation + hirsuitism AND high prevalence group: AK Jews, Hispaincs, Yugoslavs, Inuits, Italians. Check fasting 17-hydroxyprogesterone level. If elevated, get ACTH stimulation test-get thee to an endocrinologist!
|
|
In obese women with PCOS, does weight loss improve ovarian function?
|
yes
|
|
Does PCOS increase the risk of developing type 2 DM, and who should be screened?
|
2-5x increased risk of DM with PCOS. All women with PCOS should be screened with 2hr glucose tolerance test.
|
|
Does PCOS have a long-term effect on the development of cardiovasuclar disease and who should be screened?
|
All women with PCOS should be screened: BMI, fasting lipid and lipoprotein levels (high lipids in ~70%PCOS), and metabolic syndrome risk factors.
|
|
In PCOS woman not trying to conceive, what is best medical maintence therapy to treat menstrual disorders?
|
Combination low-dose OCP (decreases LH, decreases ovarian androgen production, increases SHBG), progesterone only not as good/studied, Biguanide (metformin) or Thiazolidinedione (rosiglitazone)
|
|
In PCOS woman not trying to conceive, what is best medical treatment to reduce risks of CV disease and DM?
|
lifestyle modification, insulin sinsitizing agents (metformin), statins, possibly combined low-dose OCP
|
|
In PCOS woman trying to conceive, which methods of ovulation induction are effective?
|
First line: Clomiphene citrate. Dexamethasone as adjunct may increase ovulation rates. Second line: low-dose gonadotropins, ovarian drilling (not well studied); 1st vs 2nd line-Aromatase inibitors (letrozole and anastrazole), insulin sensitizing agents (metformin preferred since category B)
|
|
What medical methods are used to treat hirsuitism in PCOS? (4 general categories)
|
No clear primary medical treatment. OCP + antiandrogen spironolactone (dose=25-100 mg BID- watch for hypokalemia and orthostatic hypotentionmay help. Other antiestrogens that are more teratogenic = flutamide and finasteride. Insulin sensitization agents have little or no clear benefit. Eflornithine topical FDA approved for femal facial hirsutism is successful 60% decrease in 6 months with 1/3 clinical success. Laser good.
|
|
Level A recommendations: 4
|
lifestyle changes are as good as or better than medication; improving insulin sensitivity decreases circulating androgen levels, improves ovulation rate, and improves glucose tolerance; first line treatment for ovulation induction is clomiphene citrate; addition of eflornithine to laser is superior to laser alone.
|
|
level B recommendations: 5
|
Screen for Type 2 DM with 2 hr GTT; screen for cardiovascular risk with BMI, fasting lipid/lipoprotein levels, metabolic syndrome risk factors; recudtion in weight if obese = improved pregnancy rates, decreaed hirsutism, improved lipids and glucose tolerance; incrased pregnancy rate buy adding clomiphene + metformin esp. in obesity; second-line for ovulation induction = exogenous gonadotropin or ovarian surgery
|
|
Level C recommendations: 4
|
Combination low dose OCP are recommended as primary treatment for menstrual disorders; if high risk group, screen for nonclassical congenital adrenal hyperplasia with 17-hyproxyprogesterone; low dose gonadotropin recommended due to increased risk of hyperstimulation and multifetal pregnancy; no clear primary treatment for hirsuitism in PCOS.
|